Search

Background Francisella tularensis , the causative agent of tularemia, is endemic throughout the Northern Hemisphere and requires as few as 10 organisms to cause disease, making this potential bioterrorism agent one of the most infectious bacterial pathogens known. Aminoglycosides, tetracyclines, and, more recently, fluoroquinolones are used for treatment of tularemia; however, data on the relative effectiveness of these and other antimicrobial classes are limited. Methods Nine databases, including Medline, Global Health, and Embase, were systematically searched for articles containing terms related to tularemia. Articles with case-level data on tularemia diagnosis, antimicrobial treatment, and patient outcome were included. Patient demographics, clinical findings, antimicrobial administration, and outcome (eg, intubation, fatality) were abstracted using a standardized form. Results Of the 8878 publications identified and screened, 410 articles describing 870 cases from 1993 to 2023 met inclusion criteria. Cases were reported from 35 countries; more than half were from the United States, Turkey, or Spain. The most common clinical forms were ulceroglandular, oropharyngeal, glandular, and pneumonic disease. Among patients treated with aminoglycosides (n = 452 [52%]), fluoroquinolones (n = 339 [39%]), or tetracyclines (n = 419 [48%]), the fatality rate was 0.7%, 0.9%, and 1.2%, respectively. Patients with pneumonic disease who received ciprofloxacin had no fatalities and the lowest rates of thoracentesis/pleural effusion drainage and intubation compared to those who received aminoglycosides and tetracyclines. Conclusions Aminoglycosides, fluoroquinolones, and tetracyclines are effective antimicrobials for treatment of tularemia, regardless of clinical manifestation. For pneumonic disease specifically, ciprofloxacin may have slight advantages compared to other antimicrobials. [ABSTRACT FROM AUTHOR]

Objective: Tularemia was first detected in Thrace region in our country and the outbreaks continued in the region over the following years. The fact that the agent has been identified in mice around Kaynarca in 2012 suggests the disease poses a risk for our region. Aim of this study was to investigate tularemia incidence and presence of Francisella tularensis in streams/mains water in a risky region of Thrace. Methods: In this study, seropositivity for tularemia was investigated in 13 villages, and 1 town in risky areas of the Thrace region. In January 2016, blood was drawn from 746 people and tularemia microagglutination tests were applied. Seropositivity was not detected. In December, 464 of 746 people were reached. Seroconversion was not observed. In addition, culture and polymerase chain reaction (PCR) procedures were applied to specimens collected from mains water and streams in 13 villages and 1 town. Results: The causative agent wasn't isolated from the cultures but F. tularensis DNAs were detected by PCR method in 2 stream, and 3 mains water samples. One of the streams passed through the village of Celaliye, which was very close to the Kaynarca, in which tularemia cases were seen in the past. The other was farther, passing through the Kavaklı town in which no cases has been reported. The mains water which were positive were from Hamzabey, Ceylanköy, and Tatarköy villages located around Kaynarca. Molecular examination after chlorination was repeated in the water sources in which positivity was detected, and it was seen that the agent was eliminated. Conclusions: In this study, incidence was calculated as zero, although the causative agent was found in the water. Although no seropositivity was detected, the detection of the agent by PCR in 5 water samples showed that the agents in the nature could reach the water resources. It has been observed that surveillance studies in risky areas could be effective in preventing possible outbreaks. [ABSTRACT FROM AUTHOR]

A 58-year-old woman was admitted to our hospital with a two week history of fever, and left axillary lymphadenopathy. She was living in a village endemic for tularemia, but she had no history of any animal contact or a tick bite. She had a wound on the second finger of her left hand which was the probable port of entry for Francisella tularensis. The clinical diagnosis of tularemia was confirmed by a microagglutination test. As this case demonstrated, other forms of tularemia other than oropharyngeal form prevalent in Turkey can be encountered among patients with fever and lymphadenopathy in endemic regions. [ABSTRACT FROM AUTHOR]